|
Market Closed -
OTC Markets
14:31:56 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | - |
| 26/08/25 | MegaGen Implant Co., Ltd. acquired All Assets of BIOLASE, Inc from BIOLASE, Inc. (OTCPK:BIOL.Q). | CI |
| 19/05/25 | EnVVeno Medical Names Jennifer Bright CFO | MT |
Company Valuation: BIOLASE, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 20.45 | 17.1 | 38.96 | 59.78 | 5.017 | 3.833 |
| Change | - | -16.35% | 127.82% | 53.42% | -91.61% | -23.61% |
| Enterprise Value (EV) 1 | 23.24 | 25.11 | 39.67 | 45.26 | 16.52 | 12.97 |
| Change | - | 8.04% | 57.99% | 14.11% | -63.49% | -21.49% |
| P/E | - | - | -0.74x | -3.45x | -0.16x | -0.04x |
| PBR | - | 46.1x | 4.11x | 2.38x | 1.03x | -15.5x |
| PEG | - | - | - | 0x | -0x | 0x |
| Capitalization / Revenue | 0.44x | 0.45x | 1.71x | 1.53x | 0.1x | 0.08x |
| EV / Revenue | 0.5x | 0.66x | 1.74x | 1.16x | 0.34x | 0.26x |
| EV / EBITDA | -1.35x | -1.72x | -2.2x | -2.77x | -0.67x | -0.9x |
| EV / EBIT | -1.28x | -1.61x | -2.14x | -2.71x | -0.65x | -0.76x |
| EV / FCF | -3.59x | -3.51x | -8.74x | -4.88x | -0.84x | -5.15x |
| FCF Yield | -27.8% | -28.5% | -11.4% | -20.5% | -119% | -19.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | - | - | -1,400 | -282.6 | -416.3 | -29.44 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 46.16 | 37.8 | 22.78 | 39.19 | 48.46 | 49.16 |
| EBITDA 1 | -17.26 | -14.64 | -18.04 | -16.32 | -24.84 | -14.34 |
| EBIT 1 | -18.2 | -15.62 | -18.54 | -16.72 | -25.34 | -17.14 |
| Net income 1 | -21.52 | -17.86 | -16.83 | -16.16 | -28.63 | -20.63 |
| Net Debt 1 | 2.792 | 8.003 | 0.701 | -14.52 | 11.51 | 9.141 |
| Reference price 2 | 2,475.000000 | 1,381.750000 | 1,041.750000 | 975.000000 | 65.000000 | 1.122000 |
| Nbr of stocks (in thousands) | 8.26 | 12.4 | 37.4 | 61.3 | 77.2 | 3,416 |
| Announcement Date | 08/03/19 | 30/03/20 | 31/03/21 | 17/03/22 | 28/03/23 | 21/03/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 36 | |
| 12.22x | 1.27x | 5.47x | 2.38% | 16.95B | |
| 7.73x | 15.03x | - | -.--% | 14.92B | |
| 27.74x | 7.02x | 16.73x | 2.57% | 12.2B | |
| Average | 15.90x | 7.78x | 11.10x | 1.65% | 11.02B | |
| Weighted average by Cap. | 15.00x | 7.52x | 10.18x | 1.63% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BIOLQ Stock
- Valuation BIOLASE, Inc.
Select your edition
All financial news and data tailored to specific country editions
